Membrane potential fluorescence: A rapid and highly sensitive assay for nicotinic receptor channel function

被引:93
作者
Fitch, RW
Xiao, YX
Kellar, KJ
Daly, JW [1 ]
机构
[1] NIDDKD, Bioorgan Chem Lab, Sect Pharmacodynam, NIH, Bethesda, MD 20892 USA
[2] Georgetown Univ, Sch Med, Dept Pharmacol, Washington, DC 20057 USA
关键词
D O I
10.1073/pnas.0630641100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Seven cell lines expressing native and transfected nicotinic receptor subtypes were evaluated functionally by using fluorescent assays based on membrane potential and calcium dynamics with "no-wash" dye systems. Both assays provided the same rank orders of potency for (+/-)-epibatidine, 2S-(-)-nicotine, 7R,9S-(-)cytisine, and 1,1-dimethyl-4-phenylpiperazinium in a cell line expressing rat alpha3beta4 receptors. Nicotinic antagonists mecamylamine and dihydro-beta-erythroidine inhibited responses in both assays. Both agonist and antagonist activity were assessed within the same experiment. Agonists seemed more potent in the membrane potential assay than in the calcium assay, whereas the converse was true for antagonists. The membrane potential assay afforded robust responses in K-177 cells expressing human alpha4beta2 receptors, in IMR-32 and SH-SY5Y cells expressing human ganglionic receptors, and in TE-671 cells expressing human neuromuscular receptors. These lines gave weak to modest calcium responses. Moreover, membrane potential responses were obtained in cell lines expressing rat alpha4beta2 and alpha4beta4 receptors, which were devoid of calcium responses. Thus, membrane potential serves as a sensitive measure of nicotinic activity, and the resulting depolarization may be as important as calcium in cell signaling.
引用
收藏
页码:4909 / 4914
页数:6
相关论文
共 42 条
[1]  
[Anonymous], 2000, HANDB EXP PHARM
[2]   A novel membrane potential-sensitive fluorescent dye improves cell-based assays for ion channels [J].
Baxter, DF ;
Kirk, M ;
Garcia, AF ;
Raimondi, A ;
Holmqvist, MH ;
Flint, K ;
Bojanic, D ;
Distefano, PS ;
Curtis, R ;
Xie, Y .
JOURNAL OF BIOMOLECULAR SCREENING, 2002, 7 (01) :79-85
[3]   Electrophysiology: A method to investigate the functional properties of ligand-gated channels [J].
Bertrand, D ;
Buisson, B ;
Krause, RM ;
Hu, HY ;
Bertrand, S .
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 1997, 17 (1-3) :227-242
[4]  
CATTERALL WA, 1975, J BIOL CHEM, V250, P1776
[5]   Characterization of the recombinant human neuronal nicotinic acetylcholine receptors α3β2 and α4β2 stably expressed in HEK293 cells [J].
Chavez-Noriega, LE ;
Gillespie, A ;
Stauderman, KA ;
Crona, JH ;
Claeps, BO ;
Elliott, KJ ;
Reid, RT ;
Rao, TS ;
Velicelebi, G ;
Harpold, MM ;
Johnson, EC ;
Corey-Naeve, J .
NEUROPHARMACOLOGY, 2000, 39 (13) :2543-2560
[6]  
CLEMENTI F, 1986, J NEUROCHEM, V47, P291
[7]  
CONNOLLY JG, 1998, DRUGS PHARM SCI, V89, P107
[8]   Overview of nicotinic receptors and their roles in the central nervous system [J].
Dani, JA .
BIOLOGICAL PSYCHIATRY, 2001, 49 (03) :166-174
[9]   Characterisation of the binding of [3H]methyllycaconitine:: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors [J].
Davies, ARL ;
Hardick, DJ ;
Blagbrough, IS ;
Potter, BVL ;
Wolstenholme, AJ ;
Wonnacott, S .
NEUROPHARMACOLOGY, 1999, 38 (05) :679-690
[10]   The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control [J].
Decker, MW ;
Meyer, MD ;
Sullivan, JP .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (10) :1819-1830